Bretylium tosylate

CAS No. 61-75-6

Bretylium tosylate( —— )

Catalog No. M20751 CAS No. 61-75-6

Bretylium tosylate is an inhibitor of the presynaptic release of vasoconstrictor neurotransmitters a available antiarrhythmic drug for ventricular arrhythmias.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 33 In Stock
5MG 53 In Stock
10MG 82 In Stock
25MG 107 In Stock
50MG 135 In Stock
100MG 161 In Stock
200MG 248 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Bretylium tosylate
  • Note
    Research use only, not for human use.
  • Brief Description
    Bretylium tosylate is an inhibitor of the presynaptic release of vasoconstrictor neurotransmitters a available antiarrhythmic drug for ventricular arrhythmias.
  • Description
    Bretylium tosylate is an inhibitor of the presynaptic release of vasoconstrictor neurotransmitters a available antiarrhythmic drug for ventricular arrhythmias.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Others
  • Indication
    xerophthalmia

Chemical Information

  • CAS Number
    61-75-6
  • Formula Weight
    414.36
  • Molecular Formula
    C18H24BrNO3S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:30 mg/mL (72.40 mM)
  • SMILES
    CC1=CC=C(C=C1)S([O-])(=O)=O.CC[N+](C)(C)CC1=CC=CC=C1Br
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Dhurandhar R W Teasdale S J Mahon W A . Bretylium Tosylate in the Management of Refractory Ventricular Fibrillation[J]. Canadian Medical Association journal 1971 105(2):161-5 passim.
molnova catalog
related products
  • Gardoside

    Gardoside is a natural product.

  • PF-04859989 HCl

    PF-04859989 HCl is a brain-penetrable and irreversible inhibitor of kynurenine amino transferase II (KAT II), which is the enzyme responsible for most of the brain synthesis of kynurenic acid.

  • Indolidan

    Indolidan (LY 195115) induces cardiovascular and adrenal hyperplastic lesions in Fischer 344 rats. Indolidan increases the risk of cardiovascular disease.